GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » SBI Holdings Inc (TSE:8473) » Definitions » Valuation Rank

SBI Holdings (TSE:8473) Valuation Rank


View and export this data going back to 2002. Start your Free Trial

What is SBI Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


SBI Holdings Valuation Rank Related Terms

Thank you for viewing the detailed overview of SBI Holdings's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


SBI Holdings (TSE:8473) Business Description

Traded in Other Exchanges
Address
1-6-1, Roppongi, Minato-ku, Tokyo, JPN, 106-6019
SBI Holdings Inc is a financial conglomerate that offers a variety of services in securities, banking, and insurance. Operations are divided into financial services, asset management, and biotechnology-related business. Many of the traditional financial offerings fall under the financial services arm and include housing loans and foreign exchange margin trading in addition to the primary banking and insurance businesses. Under the asset management business, the group invests in Japanese and international venture companies that operate in IT, biotechnology, environment/energy, and finance. Aside from financial services, cosmetics, health foods, and drugs are developed by subsidiaries in the biotech-related business.